While drug development in the West has led to new drug discoveries targeting various cancers, there has been slower progress for treatments targeting gastric cancer due to its lower incidence compared to Asian countries. Advanced gastric cancer is categorized based on HER2 expression into positive and...
The experience suggests new early end points for evaluation of neoadjuvant treatments: quality of life, quality of lymph node sterilization and extent of required gastrectomy in comparison to standard surgery.Turhal N.S.Department of Internal Medicine School of Medicine Marmara UniversityBruckner H.W....
New treatments can often seempromising4to begin with - but have disappointing results in later larger trials. However, the doctors involved in the trial - and those at the European CancerOrganisation5who have organised the conference - have never seen a cancer drug act so quickly on such a hi...
11 and that there are now newer and less complex chemotherapy regimens with activity against advanced gastric cancer.12 Are these more recently developed treatments better than the ECF regimen?
New Treatments for Advanced Gastric Cancer Introduction Gastro-esophageal cancer represents a major cause of morbidity and mortality worldwide. Whereas the incidence of distal gastric cancers has de... D Cunningham,N Starling - 《Oncology & Hematology Review》 被引量: 0发表: 2006年 New tools helps...
Advancements in understanding novel types of RCD and their implications in immune responses and tumor development have spurred the progress of therapeutic approaches against cancer. Pyroptosis, an inflammatory form of PCD, has emerged as a promising avenue for antitumor treatments. Pyroptosis was first ...
Pancreatic cancer is a highly aggressive malignancy that ranks seventh in the world for death67,68,69,70,71. New treatments are urgently needed to improve survival. Intraductal papillary mucinous neoplasm (IPMN) is a precursor to cystic pancreatic cancer72,73. Beato et al.74 established a paired...
With advances in modern biotechnology, well-designed novel antibodies are finally paving the way for successful treatments of various cancers, including precise tumor immunotherapy, in the clinic. Similar content being viewed by others Antibody-based cancer therapy ...
(GAC) and esophageal squamous cell carcinoma (ESCC), rank among the top seven most common cancers worldwide and are often diagnosed at a late stage. Advanced forms are difficult to treat, especially when initial therapies fail or cause intolerable side effects, necessitating second-line treatments...
Natural killer cell engagers in cancer immunotherapy: next generation of immuno-oncology treatments. Eur. J. Immunol. 51, 1934–1942 (2021). Article CAS PubMed Google Scholar Myers, J. A. & Miller, J. S. Exploring the NK cell platform for cancer immunotherapy. Nat. Rev. Clin. Oncol. ...